Clinical Trial Update: Jinfukang Oral Liquid Combined With Chemotherapy for Treating Driver Gene-negative Advanced NSCLC [Phase 4]

View source ↗

Summary

Phase 4 trial update on Jinfukang oral liquid combined with chemotherapy for driver gene-negative advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Jinfukang

Snippet

Sponsor: China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | Conditions: Non Small Cell Lung Cancer | Phase 4 | Status: UNKNOWN